This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ahead of the UK’s 2026 regulatory changes, which will give all new pharmacist registrants full and independent prescribing rights, a new paper offers a critique of a Pharmacist Clinician Model, outlining the need for such a model and offering a systematic approach to its safe and effective development. Reference Rushworth, G et al.
Name: Tonisha Gaitor School: University of Georgia Major/Degree Program: PharmD/MBA Anticipated Year of Graduation: 2026 What drew you to PQA and our work to improve medication use safety, adherence, and appropriate use? The main thing I want to learn this summer with PQA is how communications can be used in relation to healthcare.
As hospital pharmacists continue to expand their roles, the ability to prescribe medications either independently or in collaboration with medical prescribers presents an opportunity to alleviate the growing pressure on healthcare systems while enhancing patientcare. of all UK registered pharmacists.
On June 12, 2024, the FDA released a notice stating that it is issuing exemptions from specific requirements of the DSCSA to small pharmacies to go into effect on 11/27/2024 to ensure patient access. The exemption will last until November 27, 2026, for those small dispensers who qualify. What if I do not qualify for the exemption?
Payers are eager to engage pharmacies in driving better patientcare and outcomes, but for this effort to be successful, consistent and reliable methods are needed to measure pharmacists contributions to care. Results from this two-year project will be shared in 2026.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content